Primary Site >> Biliary tract Cancer

Gene >> ARID1A

  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers.
PMID: 24185513
 Ref: Genomic and transcriptional alterations of cholangiocarcinoma.
PMID: 24532422
Ref: New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.
PMID: 24563076
Ref: Surgical strategy for T1 gallbladder cancer: a nationwide multicenter survey in South Korea.
PMID: 24743905
Ref: Mutational landscape of intrahepatic cholangiocarcinoma.
PMID: 25526346
Ref: Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.
PMID: 25536104
 Ref: Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways.
PMID: 25966424
 Ref: Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma.
PMID: 26405193
Ref: Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
PMID: 26717940
Ref: Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design.
PMID: 26857926
Ref: The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets.
PMID: 27102149
Ref: Loss of ARID1A Expression Presents a Novel Pathway of Carcinogenesis in Biliary Carcinomas.
PMID: 27334809
Ref: Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma.
PMID: 27433094
Ref: Biliary cancer: Utility of next-generation sequencing for clinical management.
PMID: 27622582
 Ref: Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.
PMID: 28297679
Ref: Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.
PMID: 28648284
 Ref: Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine.
PMID: 29121415
Ref: Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
PMID: 29360550
Ref: Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity.
PMID: 29408647
Ref: Molecular genomic landscapes of hepatobiliary cancer.
PMID: 29573058
Ref: Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma.
PMID: 29740198
Ref: Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention.
PMID: 29848569
Ref: Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type.
PMID: 30158952